Cipla gets US regulatory nod for generic Epzicom tablets

Cipla gets US regulatory nod for generic Epzicom tabletsMumbai, April 4 (IANS) Global pharmaceutical company Cipla on Tuesday announced that it has received final approval of the US Food and Drug Administration (USFDA) for the generic version of Epzicom tablets -- for the treatment of HIV-1 infection.

"Abacavir and Lamivudine Tablets USP, 600 mg/300 mg, are AB-rated generic equivalents to the reference listed drug (RLD), Epzicom Tablets, 600 mg/300 mg of ViiV Healthcare Company and are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection," the company said in a statement.

"The product will cater to the US market and will be commercially available shortly," it added.

 

According to IMS Health -- the American firm that provides information, services and technology for the healthcare industry -- Epzicom tablets had US sales of approximately $346.3 million for the 12-month period ending February.

(This story has not been edited by Social News XYZ staff and is auto-generated from a syndicated feed.)

Facebook Comments

About VDC

Doraiah Chowdary Vundavally is a Software engineer at VTech . He is the news editor of SocialNews.XYZ and Freelance writer-contributes Telugu and English Columns on Films, Politics, and Gossips. He is the primary contributor for South Cinema Section of SocialNews.XYZ. His mission is to help to develop SocialNews.XYZ into a News website that has no bias or judgement towards any.

Share